Skip to main content
Premium Trial:

Request an Annual Quote

Genedrive, Sysmex Sign Asia Pacific Distribution Agreement for HCV Test

NEW YORK (GenomeWeb) – Genedrive announced today that it has signed a distribution agreement with Sysmex Asia Pacific for its Genedrive HCV ID kit and Genedrive PCR platform in the Asia Pacific region.

As part of the agreement, Genedrive retains responsibility for product development, quality management, and manufacturing. Sysmex will be responsible for sales, marketing, customer support, and distribution activities across the region. In addition, Genedrive currently retains the rights over the Indian market.

The companies plan to secure required regulatory approvals in individual territories across Asia.

The Genedrive HCV assay runs on the Genedrive PCR platform, and provides results directly from plasma samples without a separate viral RNA extraction step.

"This agreement provides access to another important and very relevant global region for Genedrive encompassing countries with a high HCV burden," Genedrive CEO David Budd said in a statement.

In October, Genedrive announced a distribution agreement with Sysmex Europe covering Europe, the Middle East, and Africa for the Genedrive HCV ID kit and Genedrive platform.

Also, earlier this month Genedrive said that it had terminated a distribution deal for its tuberculosis and antibiotic-resistance test with Xcelris Labs in India.

The Scan

Study Tracks Off-Target Gene Edits Linked to Epigenetic Features

Using machine learning, researchers characterize in BMC Genomics the potential off-target effects of 19 computed or experimentally determined epigenetic features during CRISPR-Cas9 editing.

Coronary Artery Disease Risk Loci, Candidate Genes Identified in GWAS Meta-Analysis

A GWAS in Nature Genetics of nearly 1.4 million coronary artery disease cases and controls focused in on more than 200 candidate causal genes, including the cell motility-related myosin gene MYO9B.

Multiple Sclerosis Contributors Found in Proteome-Wide Association Study

With a combination of genome-wide association and brain proteome data, researchers in the Annals of Clinical and Translational Neurology tracked down dozens of potential multiple sclerosis risk proteins.

Quality Improvement Study Compares Molecular Tumor Boards, Central Consensus Recommendations

With 50 simulated cancer cases, researchers in JAMA Network Open compared molecular tumor board recommendations with central consensus plans at a dozen centers in Japan.